---
figid: PMC6305585__fendo-09-00762-g0002
figtitle: ADAR1-mediated RNA editing in cancer development
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Danio rerio
- Xenopus laevis
- Homo sapiens
- Oryctolagus cuniculus
- clinical samples
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Drosophila melanogaster
- Danio rerio
- Caenorhabditis elegans
- Xenopus laevis
pmcid: PMC6305585
filename: fendo-09-00762-g0002.jpg
figlink: /pmc/articles/PMC6305585/figure/F2/
number: F2
caption: ADAR1-mediated RNA editing in cancer development. The color of the first
  arrow in each pathway indicates the mechanism (refer to Figure ) by which ADAR1
  regulates its direct targets, depicted in pink icons or shapes. Dashed lines indicate
  suggested/unproven functions/relationships. Additional activators and inhibitors
  of specific pathway steps are depicted in red and yellow rounded rectangles, respectively.
  Specific diseases and phenotypes/functions affected by ADAR1-mediated RNA editing
  are only labeled in the first appearance (ex. proliferation…etc). HCC, hepatocellular
  carcinoma; ESCC, esophageal squamous cell carcinoma; CRC, colorectal cancer; BC,
  breast cancer; CC, cervical cancer; OC, ovarian cancer; MM, multiple myeloma; MB,
  medulloblastoma; BCC, basal cell carcinoma; CML, chronic myeloid leukemia; PC, prostate
  cancer; LUAD, lung adenocarcinoma; KC, kidney cancer; BLC, bladder cancer. The figure
  was created with BioRender.
papertitle: The Role of RNA Editing in Cancer Development and Metabolic Disorders.
reftext: Che-Pei Kung, et al. Front Endocrinol (Lausanne). 2018;9:762.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7232432
figid_alias: PMC6305585__F2
figtype: Figure
redirect_from: /figures/PMC6305585__F2
ndex: a20130d0-de9d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6305585__fendo-09-00762-g0002.html
  '@type': Dataset
  description: ADAR1-mediated RNA editing in cancer development. The color of the
    first arrow in each pathway indicates the mechanism (refer to Figure ) by which
    ADAR1 regulates its direct targets, depicted in pink icons or shapes. Dashed lines
    indicate suggested/unproven functions/relationships. Additional activators and
    inhibitors of specific pathway steps are depicted in red and yellow rounded rectangles,
    respectively. Specific diseases and phenotypes/functions affected by ADAR1-mediated
    RNA editing are only labeled in the first appearance (ex. proliferation…etc).
    HCC, hepatocellular carcinoma; ESCC, esophageal squamous cell carcinoma; CRC,
    colorectal cancer; BC, breast cancer; CC, cervical cancer; OC, ovarian cancer;
    MM, multiple myeloma; MB, medulloblastoma; BCC, basal cell carcinoma; CML, chronic
    myeloid leukemia; PC, prostate cancer; LUAD, lung adenocarcinoma; KC, kidney cancer;
    BLC, bladder cancer. The figure was created with BioRender.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ODC1
  - SLC25A21
  - HCC
  - HYCC1
  - AZIN1
  - STAT3
  - CXCR1
  - BLCAP
  - GABRA3
  - AKT1
  - AKT2
  - AKT3
  - CD8A
  - CD8B
  - CCNI
  - SUFU
  - GLI1
  - DHH
  - IHH
  - SHH
  - MB
  - ADAR
  - CPEB1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - DHFR
  - ARHGEF1
  - BCR
  - LIN28A
  - PCA3
  - PC
  - PRUNE2
  - PTK2
  - HNRNPLL
  - TGFBR1
  - CXCL13
  - RSF1
  - ADARB1
  - TH
  - NT5C1A
  - Odc1
  - Azin1
  - Oaz1
  - Stat3
  - Ccr8
  - Blcap
  - Gabra3
  - Akt1
  - Ccni
  - Sufu
  - Gli1
  - Mb
  - Adar
  - Cpeb1
  - Creb1
  - Dhfr
  - Arhgef1
  - Lin28a
  - pc
  - Prune2
  - Ptk2
  - Hnrnpll
  - Tgfbr1
  - Cxcl13
  - Rsf1
  - Adarb1
  - Th
  - It
  - Lin28c
  - Pc
  - Akt
  - oc
  - Su(fu)
  - mb
  - E(spl)mbeta-HLH
  - dy
  - CrebB
  - CrebA
  - l(1)sc
  - lncRNA:let7C
  - mir-let7
  - cml
  - lin-28
  - Fak
  - blc
  - CG8677
  - cni
  - Pa
  - I-t
  - odc1
  - hccsa.2
  - azin1b
  - stat3
  - blcap
  - gabra3
  - ccni
  - sufu
  - gli1
  - cpeb1b
  - dhfr
  - lin28ab
  - prune2
  - ptk2ab
  - tgfbr1a
  - adarb1a
  - th
  - let-7
  - rsf-1
  - odc1.L
  - odc1.S
  - azin1.L
  - stat3.L
  - blcap.L
  - gabra3.L
  - cd8a.L
  - cd8a.S
  - ccni.L
  - ccni.S
  - sufu.L
  - gli1.S
  - gli1.L
  - shh.L
  - shh.S
  - adar.S
  - cpeb1.L
  - cpeb1.S
  - creb1.S
  - creb1.L
  - dhfr.L
  - bcr.L
  - bcr.S
  - nat8.6.L
  - lin28b.S
  - lin28a.S
  - lin28a.L
  - lin28b.L
  - ptk2.L
  - ptk2.S
  - tgfbr1.S
  - rsf1.S
  - tumor
  - melanoma
  - CML
---
